InteractionID	REL_ENT	REG_DIR	INDIRECT	PASSIVE	NEGATED	SENTENCE
miRNA-corp.d1.s1.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	A direct correlation was found between the downregulation of <e1>miR-200a</e1> and the upregulation of <e2>beta-catenin</e2> in human meningioma samples.
miRNA-corp.d1.s2.p3	NA	NA	FALSE	FALSE	FALSE	Thus, <e1>miR-200a</e1> appears to act as a multifunctional tumor suppressor miRNA in meningiomas through effects on the <e2>E-cadherin</e2> and Wnt/beta-catenin signaling pathways.
miRNA-corp.d1.s2.p5	NA	NA	FALSE	FALSE	FALSE	Thus, <e1>miR-200a</e1> appears to act as a multifunctional tumor suppressor miRNA in meningiomas through effects on the E-cadherin and Wnt/<e2>beta-catenin</e2> signaling pathways.
miRNA-corp.d1.s3.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	<e1>miR-200a</e1> was found to directly target <e2>beta-catenin</e2> mRNA, thereby inhibiting its translation and blocking Wnt/beta-catenin signaling, which is frequently involved in cancer.
miRNA-corp.d1.s3.p1	NA	NA	FALSE	FALSE	FALSE	<e1>miR-200a</e1> was found to directly target beta-catenin mRNA, thereby inhibiting its translation and blocking Wnt/<e2>beta-catenin</e2> signaling, which is frequently involved in cancer.
miRNA-corp.d1.s4.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Downregulation of <e1>miR-200a</e1> in meningiomas and arachnoidal cells resulted in increased expression of beta-catenin and <e2>cyclin D1</e2> involved in cell proliferation.
miRNA-corp.d1.s4.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Downregulation of <e1>miR-200a</e1> in meningiomas and arachnoidal cells resulted in increased expression of <e2>beta-catenin</e2> and cyclin D1 involved in cell proliferation.
miRNA-corp.d1.s5.p0	MIR_GENE	UP	FALSE	FALSE	FALSE	Upregulation of <e1>miR-200a</e1> decreased the expression of transcription factors ZEB1 and SIP1, with consequent increased expression of <e2>E-cadherin</e2>, an adhesion protein associated with cell differentiation.
miRNA-corp.d1.s5.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Upregulation of <e1>miR-200a</e1> decreased the expression of transcription factors <e2>ZEB1</e2> and SIP1, with consequent increased expression of E-cadherin, an adhesion protein associated with cell differentiation.
miRNA-corp.d1.s8.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Downregulated <e1>microRNA-200a</e1> in meningiomas promotes tumor growth by reducing <e2>E-cadherin</e2> and activating the Wnt/beta-catenin signaling pathway.
miRNA-corp.d1.s8.p2	NA	NA	FALSE	FALSE	FALSE	Downregulated <e1>microRNA-200a</e1> in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/<e2>beta-catenin</e2> signaling pathway.
miRNA-corp.d5.s2.p0	NA	NA	FALSE	FALSE	FALSE	Strikingly, cells with high levels of <e2>PKM2</e2> expressed lower levels of miR-326, suggestive of endogenous regulation of PKM2 by <e1>miR-326</e1>.
miRNA-corp.d5.s2.p1	MIR_GENE	NEU	TRUE	FALSE	FALSE	Strikingly, cells with high levels of PKM2 expressed lower levels of miR-326, suggestive of endogenous regulation of <e2>PKM2</e2> by <e1>miR-326</e1>.
miRNA-corp.d5.s2.p2	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Strikingly, cells with high levels of <e2>PKM2</e2> expressed lower levels of <e1>miR-326</e1>, suggestive of endogenous regulation of PKM2 by miR-326.
miRNA-corp.d5.s2.p3	NA	NA	FALSE	FALSE	FALSE	Strikingly, cells with high levels of PKM2 expressed lower levels of <e1>miR-326</e1>, suggestive of endogenous regulation of <e2>PKM2</e2> by miR-326.
miRNA-corp.d5.s4.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	<e2>Pyruvate kinase M2</e2> is a target of the tumor-suppressive <e1>microRNA-326</e1> and regulates the survival of glioma cells.
miRNA-corp.d5.s8.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Computational target gene prediction revealed <e2>pyruvate kinase type M2</e2> (PKM2) as another target of <e1>miRNA-326</e1>.
miRNA-corp.d5.s8.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Computational target gene prediction revealed pyruvate kinase type M2 (<e2>PKM2</e2>) as another target of <e1>miRNA-326</e1>.
miRNA-corp.d5.s10.p0	NA	NA	FALSE	FALSE	FALSE	To investigate whether it might be a functionally important target of <e1>miR-326</e1>, we used RNA interference to knockdown <e2>PKM2</e2> expression in glioma cells.
miRNA-corp.d19.s1.p0	NA	NA	FALSE	FALSE	FALSE	Ectopic <e1>miR-17/92</e1> expression in CGNPs synergized with exogenous Shh to increase proliferation and also enabled them to proliferate in the absence of <e2>Shh</e2>.
miRNA-corp.d19.s1.p1	MIR_GENE	NEU	FALSE	FALSE	FALSE	Ectopic <e1>miR-17/92</e1> expression in CGNPs synergized with exogenous <e2>Shh</e2> to increase proliferation and also enabled them to proliferate in the absence of Shh.
miRNA-corp.d19.s2.p0	GENE_MIR	UP	FALSE	FALSE	FALSE	In CGNPs, the Shh effector <e2>N-myc</e2>, but not Gli1, induced <e1>miR-17/92</e1> expression.
miRNA-corp.d19.s2.p1	NA	NA	FALSE	FALSE	FALSE	In CGNPs, the Shh effector N-myc, but not <e2>Gli1</e2>, induced <e1>miR-17/92</e1> expression.
miRNA-corp.d19.s2.p2	NA	NA	FALSE	FALSE	FALSE	In CGNPs, the <e2>Shh</e2> effector N-myc, but not Gli1, induced <e1>miR-17/92</e1> expression.
miRNA-corp.d19.s3.p0	NA	NA	FALSE	FALSE	FALSE	Consistent with its regulation by Shh, we observed that <e2>Shh</e2> treatment of primary cerebellar granule neuron precursors (CGNP), proposed cells of origin for the Shh-associated medulloblastomas, resulted in increased <e1>miR-17/92</e1> expression.
miRNA-corp.d19.s3.p2	NA	NA	FALSE	FALSE	FALSE	Consistent with its regulation by Shh, we observed that Shh treatment of primary cerebellar granule neuron precursors (CGNP), proposed cells of origin for the <e2>Shh</e2>-associated medulloblastomas, resulted in increased <e1>miR-17/92</e1> expression.
miRNA-corp.d19.s3.p3	NA	NA	FALSE	FALSE	FALSE	Consistent with its regulation by <e2>Shh</e2>, we observed that Shh treatment of primary cerebellar granule neuron precursors (CGNP), proposed cells of origin for the Shh-associated medulloblastomas, resulted in increased <e1>miR-17/92</e1> expression.
miRNA-corp.d19.s4.p1	MIR_GENE	UP	FALSE	FALSE	FALSE	Medulloblastomas in which <e1>miR-17/92</e1> was up-regulated also had elevated levels of <e2>MYC</e2>/MYCN expression.
miRNA-corp.d19.s4.p2	MIR_GENE	UP	FALSE	FALSE	FALSE	Medulloblastomas in which <e1>miR-17/92</e1> was up-regulated also had elevated levels of MYC/<e2>MYCN</e2> expression.
miRNA-corp.d19.s5.p2	NA	NA	FALSE	FALSE	FALSE	Expression of <e1>miR-17/92</e1> was highest in the subgroup of medulloblastomas associated with activation of the <e2>sonic hedgehog</e2> (Shh) signaling pathway compared with other subgroups of medulloblastoma.
miRNA-corp.d19.s5.p3	NA	NA	FALSE	FALSE	FALSE	Expression of <e1>miR-17/92</e1> was highest in the subgroup of medulloblastomas associated with activation of the sonic hedgehog (<e2>Shh</e2>) signaling pathway compared with other subgroups of medulloblastoma.
miRNA-corp.d19.s9.p0	NA	NA	FALSE	FALSE	FALSE	The <e1>miR-17/92</e1> polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in <e2>sonic hedgehog</e2>-treated cerebellar neural precursors.
miRNA-corp.d19.s9.p2	GENE_MIR	UP	FALSE	TRUE	FALSE	The <e1>miR-17/92</e1> polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by <e2>N-myc</e2> in sonic hedgehog-treated cerebellar neural precursors.
miRNA-corp.d19.s9.p3	NA	NA	FALSE	FALSE	FALSE	The <e1>miR-17/92</e1> polycistron is up-regulated in <e2>sonic hedgehog</e2>-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
miRNA-corp.d20.s7.p2	MIR_GENE	TARGET	FALSE	FALSE	FALSE	In this paper, we present for the first time evidence that microRNAs (miRNAs), including <e1>miR-26a, -34a, -145</e1>, and let-7b, may directly regulate <e2>IFN-beta</e2> in human and macaque cells.
miRNA-corp.d20.s7.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	In this paper, we present for the first time evidence that microRNAs (miRNAs), including miR-26a, -34a, -145, and <e1>let-7b</e1>, may directly regulate <e2>IFN-beta</e2> in human and macaque cells.
miRNA-corp.d22.s3.p0	MIR_GENE	TARGET	TRUE	FALSE	FALSE	Similar results were obtained by depletion of endogenous <e2>polypyrimidine tract binding protein</e2> 1 (PTBP1) in cells, a recognized <e1>miR-124</e1> target gene.
miRNA-corp.d22.s3.p1	MIR_GENE	TARGET	TRUE	FALSE	FALSE	Similar results were obtained by depletion of endogenous polypyrimidine tract binding protein 1 (<e2>PTBP1</e2>) in cells, a recognized <e1>miR-124</e1> target gene.
miRNA-corp.d22.s7.p0	NA	NA	FALSE	FALSE	FALSE	Lack of miRNAs in post-mitotic neurons in vivo is associated with <e2>APP</e2> exons 7 and 8 inclusion, while ectopic expression of <e1>miR-124</e1>, an abundant neuronal-specific miRNA, reversed these effects in cultured neurons.
miRNA-corp.d30.s3.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Utilizing human cell lines, we demonstrate that miRNAs <e1>hsa-mir-106a</e1> and hsa-mir-520c bind to their predicted target sequences in the <e2>APP</e2> 3'UTR and negatively regulate reporter gene expression.
miRNA-corp.d30.s3.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Utilizing human cell lines, we demonstrate that miRNAs hsa-mir-106a and <e1>hsa-mir-520c</e1> bind to their predicted target sequences in the <e2>APP</e2> 3'UTR and negatively regulate reporter gene expression.
miRNA-corp.d33.s1.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The bifunctional microRNA <e1>miR-9</e1>/miR-9* regulates <e2>REST</e2> and CoREST and is downregulated in Huntington's disease.
miRNA-corp.d33.s1.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The bifunctional microRNA <e1>miR-9</e1>/miR-9* regulates REST and <e2>CoREST</e2> and is downregulated in Huntington's disease.
miRNA-corp.d33.s1.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The bifunctional microRNA miR-9/<e1>miR-9</e1>* regulates <e2>REST</e2> and CoREST and is downregulated in Huntington's disease.
miRNA-corp.d33.s1.p4	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The bifunctional microRNA miR-9/<e1>miR-9</e1>* regulates REST and <e2>CoREST</e2> and is downregulated in Huntington's disease.
miRNA-corp.d33.s6.p0	NA	NA	FALSE	FALSE	FALSE	Interestingly, one of these, the bifunctional brain enriched miR-9/<e1>miR-9</e1>*, targets two components of the REST complex: miR-9 targets <e2>REST</e2> and miR-9* targets CoREST.
miRNA-corp.d33.s6.p1	NA	NA	FALSE	FALSE	FALSE	Interestingly, one of these, the bifunctional brain enriched miR-9/<e1>miR-9</e1>*, targets two components of the REST complex: miR-9 targets REST and miR-9* targets <e2>CoREST</e2>.
miRNA-corp.d33.s6.p2	NA	NA	FALSE	FALSE	FALSE	Interestingly, one of these, the bifunctional brain enriched <e1>miR-9</e1>/miR-9*, targets two components of the REST complex: miR-9 targets <e2>REST</e2> and miR-9* targets CoREST.
miRNA-corp.d33.s6.p3	NA	NA	FALSE	FALSE	FALSE	Interestingly, one of these, the bifunctional brain enriched <e1>miR-9</e1>/miR-9*, targets two components of the REST complex: miR-9 targets REST and miR-9* targets <e2>CoREST</e2>.
miRNA-corp.d33.s6.p4	NA	NA	FALSE	FALSE	FALSE	Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two components of the REST complex; miR-9 targets <e2>REST</e2> and <e1>miR-9</e1>* targets CoREST.
miRNA-corp.d33.s6.p5	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two components of the REST complex; miR-9 targets REST and <e1>miR-9</e1>* targets <e2>CoREST</e2>.
miRNA-corp.d33.s6.p6	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two components of the REST complex; <e1>miR-9</e1> targets <e2>REST</e2> and miR-9* targets CoREST.
miRNA-corp.d33.s6.p7	NA	NA	FALSE	FALSE	FALSE	Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two components of the REST complex; <e1>miR-9</e1> targets REST and miR-9* targets <e2>CoREST</e2>.
miRNA-corp.d34.s4.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Western blot analysis demonstrated that <e2>PTEN</e2> and Bcl-2 were involved in <e1>miR-21</e1>-mediated cellular effects.
miRNA-corp.d34.s4.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Western blot analysis demonstrated that PTEN and <e2>Bcl-2</e2> were involved in <e1>miR-21</e1>-mediated cellular effects.
miRNA-corp.d37.s0.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells; <e1>miR-146a</e1> targets <e2>TBP</e2>.
miRNA-corp.d37.s5.p0	NA	NA	FALSE	FALSE	FALSE	Using luciferase reporter assays with 3'-UTRs of <e2>TBP</e2>, over-expression and inhibition of <e1>miR-146a</e1>, we showed that miR-146a targets TBP.
miRNA-corp.d37.s5.p1	NA	NA	FALSE	FALSE	FALSE	Using luciferase reporter assays with 3'-UTRs of TBP, over-expression and inhibition of <e1>miR-146a</e1>, we showed that miR-146a targets <e2>TBP</e2>.
miRNA-corp.d37.s5.p2	NA	NA	FALSE	FALSE	FALSE	Using luciferase reporter assays with 3'-UTRs of <e2>TBP</e2>, over-expression and inhibition of miR-146a, we showed that <e1>miR-146a</e1> targets TBP.
miRNA-corp.d37.s5.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Using luciferase reporter assays with 3'-UTRs of TBP, over-expression and inhibition of miR-146a, we showed that <e1>miR-146a</e1> targets <e2>TBP</e2>.
miRNA-corp.d37.s6.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	It has been predicted that <e1>miR-146a</e1> may target <e2>Tata Binding Protein</e2> (TBP).
miRNA-corp.d37.s6.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	It has been predicted that <e1>miR-146a</e1> may target Tata Binding Protein (<e2>TBP</e2>).
miRNA-corp.d37.s7.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Regulation of <e2>TBP</e2> by <e1>miR-146a</e1> may contribute to HD pathogenesis.
miRNA-corp.d47.s4.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Indeed, <e1>miR-485-5p</e1> and BACE1-antisense compete for binding within the same region in the open reading frame of the <e2>BACE1</e2> mRNA.
miRNA-corp.d47.s5.p0	NA	NA	FALSE	FALSE	FALSE	RESULTS; We report here that BACE1-antisense prevents miRNA-induced repression of <e2>BACE1</e2> mRNA by masking the binding site for <e1>miR-485-5p</e1>.
miRNA-corp.d47.s8.p0	NA	NA	FALSE	FALSE	FALSE	We observed opposing effects of BACE1-antisense and <e1>miR-485-5p</e1> on BACE1 protein in vitro and showed that Locked Nucleic Acid-antimiR mediated knockdown of miR-485-5p as well as BACE1-antisense over-expression can prevent the miRNA-induced <e2>BACE1</e2> suppression.
miRNA-corp.d47.s8.p1	NA	NA	FALSE	FALSE	FALSE	We observed opposing effects of BACE1-antisense and <e1>miR-485-5p</e1> on <e2>BACE1</e2> protein in vitro and showed that Locked Nucleic Acid-antimiR mediated knockdown of miR-485-5p as well as BACE1-antisense over-expression can prevent the miRNA-induced BACE1 suppression.
miRNA-corp.d47.s8.p2	NA	NA	FALSE	FALSE	FALSE	We observed opposing effects of BACE1-antisense and miR-485-5p on BACE1 protein in vitro and showed that Locked Nucleic Acid-antimiR mediated knockdown of <e1>miR-485-5p</e1> as well as BACE1-antisense over-expression can prevent the miRNA-induced <e2>BACE1</e2> suppression.
miRNA-corp.d47.s8.p3	NA	NA	FALSE	FALSE	FALSE	We observed opposing effects of BACE1-antisense and miR-485-5p on <e2>BACE1</e2> protein in vitro and showed that Locked Nucleic Acid-antimiR mediated knockdown of <e1>miR-485-5p</e1> as well as BACE1-antisense over-expression can prevent the miRNA-induced BACE1 suppression.
miRNA-corp.d48.s5.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Antagomir-mediated prevention of <e1>mir-145</e1> expression led to an increased protein expression of its downstream target <e2>superoxide dismutase-2</e2> in the postischemic brain.
miRNA-corp.d51.s3.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	Adjusted <e1>miR-107</e1> and <e2>BACE1</e2> mRNA levels tended to correlate negatively (trend with regression P< 0.07).
miRNA-corp.d53.s3.p1	NA	NA	FALSE	FALSE	FALSE	To investigate the involvement of let-7i, <e1>miR-27a</e1>, and miR-150 in CM-resistant mice, we assessed the expression levels in gamma interferon knockout (<e2>IFN</e2>-γ(-/-)) mice on a C57BL/6 genetic background.
miRNA-corp.d53.s3.p2	NA	NA	FALSE	FALSE	FALSE	To investigate the involvement of let-7i, <e1>miR-27a</e1>, and miR-150 in CM-resistant mice, we assessed the expression levels in <e2>gamma interferon</e2> knockout (IFN-γ(-/-)) mice on a C57BL/6 genetic background.
miRNA-corp.d53.s3.p4	NA	NA	FALSE	FALSE	FALSE	To investigate the involvement of let-7i, miR-27a, and <e1>miR-150</e1> in CM-resistant mice, we assessed the expression levels in gamma interferon knockout (<e2>IFN</e2>-γ(-/-)) mice on a C57BL/6 genetic background.
miRNA-corp.d53.s3.p5	NA	NA	FALSE	FALSE	FALSE	To investigate the involvement of let-7i, miR-27a, and <e1>miR-150</e1> in CM-resistant mice, we assessed the expression levels in <e2>gamma interferon</e2> knockout (IFN-γ(-/-)) mice on a C57BL/6 genetic background.
miRNA-corp.d53.s3.p7	NA	NA	FALSE	FALSE	FALSE	To investigate the involvement of <e1>let-7i</e1>, miR-27a, and miR-150 in CM-resistant mice, we assessed the expression levels in gamma interferon knockout (<e2>IFN</e2>-γ(-/-)) mice on a C57BL/6 genetic background.
miRNA-corp.d53.s3.p8	NA	NA	FALSE	FALSE	FALSE	To investigate the involvement of <e1>let-7i</e1>, miR-27a, and miR-150 in CM-resistant mice, we assessed the expression levels in <e2>gamma interferon</e2> knockout (IFN-γ(-/-)) mice on a C57BL/6 genetic background.
miRNA-corp.d53.s9.p0	NA	NA	FALSE	FALSE	FALSE	The expression of <e1>let-7i</e1>, miR-27a, and miR-150 was unchanged in both wild-type (WT) and <e2>IFN</e2>-γ(-/-) mice following infection.
miRNA-corp.d53.s9.p2	NA	NA	FALSE	FALSE	FALSE	The expression of let-7i, <e1>miR-27a</e1>, and miR-150 was unchanged in both wild-type (WT) and <e2>IFN</e2>-γ(-/-) mice following infection.
miRNA-corp.d53.s9.p4	NA	NA	FALSE	FALSE	FALSE	The expression of let-7i, miR-27a, and <e1>miR-150</e1> was unchanged in both wild-type (WT) and <e2>IFN</e2>-γ(-/-) mice following infection.
miRNA-corp.d56.s5.p0	NA	NA	FALSE	FALSE	FALSE	By incorporating <e1>miR-126</e1> target sequences into a GALC-expressing vector, we suppressed <e2>GALC</e2> expression in HSCs while maintaining robust expression in mature hematopoietic cells.
miRNA-corp.d56.s5.p1	MIR_GENE	DOWN	TRUE	FALSE	FALSE	By incorporating <e1>miR-126</e1> target sequences into a GALC-expressing vector, we suppressed <e2>GALC</e2> expression in HSCs while maintaining robust expression in mature hematopoietic cells.
miRNA-corp.d56.s5.p2	NA	NA	FALSE	FALSE	FALSE	By incorporating <e1>miR-126</e1> target sequences into a <e2>GALC</e2>-expressing vector, we suppressed GALC expression in HSCs while maintaining robust expression in mature hematopoietic cells.
miRNA-corp.d60.s0.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	Through various experimental approaches, we validated computational predictions and demonstrated that miR-298 and <e1>miR-328</e1> recognize specific binding sites in the 3'-UTR of BACE1 mRNA and exert regulatory effects on <e2>BACE1</e2> protein expression in cultured neuronal cells.
miRNA-corp.d60.s0.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Through various experimental approaches, we validated computational predictions and demonstrated that miR-298 and <e1>miR-328</e1> recognize specific binding sites in the 3'-UTR of <e2>BACE1</e2> mRNA and exert regulatory effects on BACE1 protein expression in cultured neuronal cells.
miRNA-corp.d60.s0.p2	MIR_GENE	NEU	FALSE	FALSE	FALSE	Through various experimental approaches, we validated computational predictions and demonstrated that <e1>miR-298</e1> and miR-328 recognize specific binding sites in the 3'-UTR of BACE1 mRNA and exert regulatory effects on <e2>BACE1</e2> protein expression in cultured neuronal cells.
miRNA-corp.d60.s0.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Through various experimental approaches, we validated computational predictions and demonstrated that <e1>miR-298</e1> and miR-328 recognize specific binding sites in the 3'-UTR of <e2>BACE1</e2> mRNA and exert regulatory effects on BACE1 protein expression in cultured neuronal cells.
miRNA-corp.d68.s0.p7	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Aberrant microRNA expression in the brains of neurodegenerative diseases; <e1>miR-29a</e1> decreased in Alzheimer disease brains targets <e2>neurone navigator 3</e2>.  AIMS.;  MicroRNAs (miRNAs) are small non-coding RNAs that regulate translational repression of target mRNAs. 
miRNA-corp.d68.s1.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	<e1>MiR-29a</e1>-mediated down-regulation of <e2>NAV3</e2> was verified by the luciferase reporter assay.
miRNA-corp.d68.s3.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The database search on TargetScan, PicTar and miRBase Target identified <e2>neurone navigator 3</e2> (NAV3), a regulator of axon guidance, as a principal target of <e1>miR-29a</e1>, and actually NAV3 mRNA levels were elevated in AD brains.
miRNA-corp.d68.s3.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The database search on TargetScan, PicTar and miRBase Target identified neurone navigator 3 (<e2>NAV3</e2>), a regulator of axon guidance, as a principal target of <e1>miR-29a</e1>, and actually NAV3 mRNA levels were elevated in AD brains.
miRNA-corp.d68.s3.p2	NA	NA	FALSE	FALSE	FALSE	The database search on TargetScan, PicTar and miRBase Target identified neurone navigator 3 (NAV3), a regulator of axon guidance, as a principal target of <e1>miR-29a</e1>, and actually <e2>NAV3</e2> mRNA levels were elevated in AD brains.
miRNA-corp.d68.s10.p0	NA	NA	FALSE	FALSE	FALSE	By immunohistochemistry, <e2>NAV3</e2> expression was most evidently enhanced in degenerating pyramidal neurones in the cerebral cortex of AD. CONCLUSIONS: These observations suggest the hypothesis that underexpression of <e1>miR-29a</e1> affects neurodegenerative processes by enhancing neuronal NAV3 expression in AD brains.
miRNA-corp.d68.s10.p3	MIR_GENE	DOWN	TRUE	FALSE	FALSE	By immunohistochemistry, NAV3 expression was most evidently enhanced in degenerating pyramidal neurones in the cerebral cortex of AD. CONCLUSIONS; These observations suggest the hypothesis that underexpression of <e1>miR-29a</e1> affects neurodegenerative processes by enhancing neuronal <e2>NAV3</e2> expression in AD brains.
miRNA-corp.d71.s5.p2	NA	NA	FALSE	FALSE	FALSE	Interestingly the gene locus of one miRNA, <e1>miR-175</e1>, is a candidate region for two neurologic diseases: early-onset parkinsonism (<e2>Waisman syndrome</e2>) and X-linked mental retardation (MRX3).
miRNA-corp.d71.s5.p3	NA	NA	FALSE	FALSE	FALSE	Interestingly the gene locus of one miRNA, <e1>miR-175</e1>, is a candidate region for two neurologic diseases: early-onset parkinsonism (Waisman syndrome) and X-linked mental retardation (<e2>MRX3</e2>).
miRNA-corp.d73.s4.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	<e1>miR-15a</e1> and miR-16-1 function by targeting multiple oncogenes, including <e2>BCL2</e2>, MCL1, CCND1, and WNT3A.
miRNA-corp.d73.s4.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	<e1>miR-15a</e1> and miR-16-1 function by targeting multiple oncogenes, including BCL2, <e2>MCL1</e2>, CCND1, and WNT3A.
miRNA-corp.d73.s4.p2	MIR_GENE	TARGET	FALSE	FALSE	FALSE	<e1>miR-15a</e1> and miR-16-1 function by targeting multiple oncogenes, including BCL2, MCL1, <e2>CCND1</e2>, and WNT3A.
miRNA-corp.d73.s4.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	<e1>miR-15a</e1> and miR-16-1 function by targeting multiple oncogenes, including BCL2, MCL1, CCND1, and <e2>WNT3A</e2>.
miRNA-corp.d73.s4.p4	MIR_GENE	TARGET	FALSE	FALSE	FALSE	miR-15a and <e1>miR-16-1</e1> function by targeting multiple oncogenes, including <e2>BCL2</e2>, MCL1, CCND1, and WNT3A.
miRNA-corp.d73.s4.p5	MIR_GENE	TARGET	FALSE	FALSE	FALSE	miR-15a and <e1>miR-16-1</e1> function by targeting multiple oncogenes, including BCL2, <e2>MCL1</e2>, CCND1, and WNT3A.
miRNA-corp.d73.s4.p6	MIR_GENE	TARGET	FALSE	FALSE	FALSE	miR-15a and <e1>miR-16-1</e1> function by targeting multiple oncogenes, including BCL2, MCL1, <e2>CCND1</e2>, and WNT3A.
miRNA-corp.d73.s4.p7	MIR_GENE	TARGET	FALSE	FALSE	FALSE	miR-15a and <e1>miR-16-1</e1> function by targeting multiple oncogenes, including BCL2, MCL1, CCND1, and <e2>WNT3A</e2>.
miRNA-corp.d83.s4.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Computational analysis predicted <e2>fibroblast growth factor-2</e2> (FGF-2) as the strongest target gene for <e1>hsa-miR15b</e1>.
miRNA-corp.d83.s4.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Computational analysis predicted fibroblast growth factor-2 (<e2>FGF-2</e2>) as the strongest target gene for <e1>hsa-miR15b</e1>.
miRNA-corp.d89.s2.p0	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and <e1>miR-65</e1> and are overexpressed in <e2>alpha-synuclein</e2> transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and <e2>ptc-1</e2> genes are target candidates for miR-64 and <e1>miR-65</e1> and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p2	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the <e2>alpha-synuclein</e2> transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and <e1>miR-65</e1> and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; <e2>mdl-1</e2> and ptc-1 genes are target candidates for miR-64 and <e1>miR-65</e1> and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p4	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the <e2>alpha-synuclein</e2> and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and <e1>miR-65</e1> and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p5	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of <e1>let-7</e1> family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in <e2>alpha-synuclein</e2> transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p6	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of <e1>let-7</e1> family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and <e2>ptc-1</e2> genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p7	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the <e2>alpha-synuclein</e2> transgenic and cat-1 strains, and members of <e1>let-7</e1> family co-underexpressed in the alpha-synuclein and pdr-1 strains.;  mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. 
miRNA-corp.d89.s2.p8	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of <e1>let-7</e1> family co-underexpressed in the alpha-synuclein and pdr-1 strains; <e2>mdl-1</e2> and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p9	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of <e1>let-7</e1> family co-underexpressed in the <e2>alpha-synuclein</e2> and pdr-1 strains.;  mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. 
miRNA-corp.d89.s2.p10	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR</e1>-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in <e2>alpha-synuclein</e2> transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p11	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR</e1>-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and <e2>ptc-1</e2> genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p12	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR</e1>-65 are co-underexpressed in the <e2>alpha-synuclein</e2> transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains.;  mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. 
miRNA-corp.d89.s2.p13	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR</e1>-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; <e2>mdl-1</e2> and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p14	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR</e1>-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the <e2>alpha-synuclein</e2> and pdr-1 strains.;  mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. 
miRNA-corp.d89.s2.p15	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in <e2>alpha-synuclein</e2> transgenic as well as <e1>miR-64/65</e1> (tm3711) knockout animals.
miRNA-corp.d89.s2.p16	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and <e2>ptc-1</e2> genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as <e1>miR-64/65</e1> (tm3711) knockout animals.
miRNA-corp.d89.s2.p17	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the <e2>alpha-synuclein</e2> transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as <e1>miR-64/65</e1> (tm3711) knockout animals.
miRNA-corp.d89.s2.p18	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; <e2>mdl-1</e2> and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as <e1>miR-64/65</e1> (tm3711) knockout animals.
miRNA-corp.d89.s2.p19	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the <e2>alpha-synuclein</e2> and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as <e1>miR-64/65</e1> (tm3711) knockout animals.
miRNA-corp.d89.s2.p20	NA	NA	FALSE	FALSE	FALSE	The family of <e1>miR-64</e1> and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in <e2>alpha-synuclein</e2> transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p21	NA	NA	FALSE	FALSE	FALSE	The family of <e1>miR-64</e1> and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and <e2>ptc-1</e2> genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p22	NA	NA	FALSE	FALSE	FALSE	The family of <e1>miR-64</e1> and miR-65 are co-underexpressed in the <e2>alpha-synuclein</e2> transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains.;  mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. 
miRNA-corp.d89.s2.p23	NA	NA	FALSE	FALSE	FALSE	The family of <e1>miR-64</e1> and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; <e2>mdl-1</e2> and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p24	NA	NA	FALSE	FALSE	FALSE	The family of <e1>miR-64</e1> and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the <e2>alpha-synuclein</e2> and pdr-1 strains.;  mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. 
miRNA-corp.d89.s2.p25	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR-65</e1> are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in <e2>alpha-synuclein</e2> transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p26	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR-65</e1> are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and <e2>ptc-1</e2> genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p27	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR-65</e1> are co-underexpressed in the <e2>alpha-synuclein</e2> transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains.;  mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. 
miRNA-corp.d89.s2.p28	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR-65</e1> are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; <e2>mdl-1</e2> and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p29	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and <e1>miR-65</e1> are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the <e2>alpha-synuclein</e2> and pdr-1 strains.;  mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. 
miRNA-corp.d89.s2.p30	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for <e1>miR-64</e1> and miR-65 and are overexpressed in <e2>alpha-synuclein</e2> transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p31	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and <e2>ptc-1</e2> genes are target candidates for <e1>miR-64</e1> and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p32	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the <e2>alpha-synuclein</e2> transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for <e1>miR-64</e1> and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p33	MIR_GENE	TARGET	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; <e2>mdl-1</e2> and ptc-1 genes are target candidates for <e1>miR-64</e1> and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d89.s2.p34	NA	NA	FALSE	FALSE	FALSE	The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the <e2>alpha-synuclein</e2> and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for <e1>miR-64</e1> and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals.
miRNA-corp.d92.s4.p0	NA	NA	FALSE	FALSE	FALSE	Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; <e1>miR-133b</e1> is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; miR-212 affects production of striatal <e2>brain-derived neurotrophic factor</e2> and synaptic plasticity upon cocaine.
miRNA-corp.d92.s4.p1	NA	NA	FALSE	FALSE	FALSE	Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction;  miR-16 causes adaptive changes in production of the serotonin transporter; <e1>miR-133b</e1> is specifically expressed in midbrain dopaminergic neurons, and regulates the production of <e2>tyrosine hydroxylase</e2> and the dopamine transporter.;  miR-212 affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine. 
miRNA-corp.d92.s4.p9	NA	NA	FALSE	FALSE	FALSE	Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction: <e1>miR-16</e1> causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; miR-212 affects production of striatal <e2>brain-derived neurotrophic factor</e2> and synaptic plasticity upon cocaine.
miRNA-corp.d92.s4.p10	NA	NA	FALSE	FALSE	FALSE	Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction: <e1>miR-16</e1> causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of <e2>tyrosine hydroxylase</e2> and the dopamine transporter; miR-212 affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.
miRNA-corp.d92.s4.p12	MIR_GENE	NEU	FALSE	FALSE	FALSE	Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction;  miR-16 causes adaptive changes in production of the serotonin transporter;  miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of tyrosine hydroxylase and the dopamine transporter; <e1>miR-212</e1> affects production of striatal <e2>brain-derived neurotrophic factor</e2> and synaptic plasticity upon cocaine.
miRNA-corp.d92.s4.p13	NA	NA	FALSE	FALSE	FALSE	Recent studies have identified changes of several specific miRNA expression profiles and polymorphisms affecting the interactions between miRNAs and their targets in various brain disorders, including addiction: miR-16 causes adaptive changes in production of the serotonin transporter; miR-133b is specifically expressed in midbrain dopaminergic neurons, and regulates the production of <e2>tyrosine hydroxylase</e2> and the dopamine transporter; <e1>miR-212</e1> affects production of striatal brain-derived neurotrophic factor and synaptic plasticity upon cocaine.
miRNA-corp.d94.s2.p0	NA	NA	FALSE	FALSE	FALSE	In vitro, anti-miRNA-125b added exogenously to <e2>IL-6</e2>-stressed NHA cultures attenuated both glial cell proliferation and increased the expression of the cyclin-dependent kinase inhibitor 2A (CDKN2A), a <e1>miRNA-125b</e1> target and negative regulator of cell growth.
miRNA-corp.d94.s2.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	In vitro, anti-miRNA-125b added exogenously to IL-6-stressed NHA cultures attenuated both glial cell proliferation and increased the expression of the <e2>cyclin-dependent kinase inhibitor 2A</e2> (CDKN2A), a <e1>miRNA-125b</e1> target and negative regulator of cell growth.
miRNA-corp.d94.s2.p2	MIR_GENE	TARGET	FALSE	FALSE	FALSE	In vitro, anti-miRNA-125b added exogenously to IL-6-stressed NHA cultures attenuated both glial cell proliferation and increased the expression of the cyclin-dependent kinase inhibitor 2A (<e2>CDKN2A</e2>), a <e1>miRNA-125b</e1> target and negative regulator of cell growth.
miRNA-corp.d94.s3.p0	GENE_MIR	UP	FALSE	FALSE	FALSE	Here we report that the levels of a human brain-enriched <e1>miRNA-125b</e1> are up-regulated in <e2>interleukin-6</e2> (IL-6)-stressed normal human astrocytes (NHA), a treatment known to induce astrogliosis.
miRNA-corp.d94.s3.p1	GENE_MIR	UP	FALSE	FALSE	FALSE	Here we report that the levels of a human brain-enriched <e1>miRNA-125b</e1> are up-regulated in interleukin-6 (<e2>IL-6</e2>)-stressed normal human astrocytes (NHA), a treatment known to induce astrogliosis.
miRNA-corp.d94.s5.p4	MIR_GENE	UP	FALSE	FALSE	FALSE	A strong positive correlation between <e1>miRNA-125b</e1> abundance and the glial cell markers <e2>glial fibrillary acidic protein</e2> (GFAP) and vimentin, and CDKN2A down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.
miRNA-corp.d94.s5.p5	MIR_GENE	UP	FALSE	FALSE	FALSE	A strong positive correlation between <e1>miRNA-125b</e1> abundance and the glial cell markers glial fibrillary acidic protein (<e2>GFAP</e2>) and vimentin, and CDKN2A down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.
miRNA-corp.d94.s5.p6	MIR_GENE	DOWN	FALSE	FALSE	FALSE	A strong positive correlation between <e1>miRNA-125b</e1> abundance and the glial cell markers glial fibrillary acidic protein (GFAP) and vimentin, and <e2>CDKN2A</e2> down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.
miRNA-corp.d94.s5.p7	MIR_GENE	UP	FALSE	FALSE	FALSE	A strong positive correlation between <e1>miRNA-125b</e1> abundance and the glial cell markers glial fibrillary acidic protein (GFAP) and <e2>vimentin</e2>, and CDKN2A down-regulation was noted in advanced Alzheimer's disease (AD) and in Down's syndrome (DS) brain, chronic neurological disorders associated with astrogliosis.
miRNA-corp.d95.s2.p0	NA	NA	FALSE	FALSE	FALSE	We reveal the relative contribution of each subgroup to clinical outcome as a whole and show that a previously unidentified molecular subgroup, characterized genetically by c-<e2>MYC</e2> copy number gains and transcriptionally by enrichment of photoreceptor pathways and increased <e1>miR-183∼96∼182</e1> expression, is associated with significantly lower rates of event-free and overall survivals.
miRNA-corp.d98.s0.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	BACE1 mRNA levels tended to increase as miR-107 levels decreased in the progression of AD. Cell culture reporter assays performed with a subset of the predicted <e1>miR-107</e1> binding sites indicate the presence of at least one physiological miR-107 miRNA recognition sequence in the 3'-UTR of <e2>BACE1</e2> mRNA.
miRNA-corp.d98.s0.p1	NA	NA	FALSE	FALSE	FALSE	<e2>BACE1</e2> mRNA levels tended to increase as miR-107 levels decreased in the progression of AD. Cell culture reporter assays performed with a subset of the predicted <e1>miR-107</e1> binding sites indicate the presence of at least one physiological miR-107 miRNA recognition sequence in the 3'-UTR of BACE1 mRNA.
miRNA-corp.d98.s0.p3	NA	NA	FALSE	FALSE	FALSE	BACE1 mRNA levels tended to increase as <e1>miR-107</e1> levels decreased in the progression of AD. Cell culture reporter assays performed with a subset of the predicted miR-107 binding sites indicate the presence of at least one physiological miR-107 miRNA recognition sequence in the 3'-UTR of <e2>BACE1</e2> mRNA.
miRNA-corp.d98.s0.p4	MIR_GENE	DOWN	TRUE	FALSE	FALSE	<e2>BACE1</e2> mRNA levels tended to increase as <e1>miR-107</e1> levels decreased in the progression of AD. Cell culture reporter assays performed with a subset of the predicted miR-107 binding sites indicate the presence of at least one physiological miR-107 miRNA recognition sequence in the 3'-UTR of BACE1 mRNA.
miRNA-corp.d98.s0.p6	MIR_GENE	TARGET	FALSE	FALSE	FALSE	BACE1 mRNA levels tended to increase as miR-107 levels decreased in the progression of AD. Cell culture reporter assays performed with a subset of the predicted miR-107 binding sites indicate the presence of at least one physiological <e1>miR-107</e1> miRNA recognition sequence in the 3'-UTR of <e2>BACE1</e2> mRNA.
miRNA-corp.d98.s0.p7	NA	NA	FALSE	FALSE	FALSE	<e2>BACE1</e2> mRNA levels tended to increase as miR-107 levels decreased in the progression of AD. Cell culture reporter assays performed with a subset of the predicted miR-107 binding sites indicate the presence of at least one physiological <e1>miR-107</e1> miRNA recognition sequence in the 3'-UTR of BACE1 mRNA.
miRNA-corp.d98.s1.p0	MIR_GENE	TARGET	TRUE	FALSE	FALSE	Computational analysis predicted that the 3'-untranslated region (UTR) of beta-site amyloid precursor protein-cleaving enzyme 1 (<e2>BACE1</e2>) mRNA is targeted multiply by <e1>miR-107</e1>.
miRNA-corp.d98.s1.p1	MIR_GENE	TARGET	TRUE	FALSE	FALSE	Computational analysis predicted that the 3'-untranslated region (UTR) of <e2>beta-site amyloid precursor protein-cleaving enzyme 1</e2> (BACE1) mRNA is targeted multiply by <e1>miR-107</e1>.
miRNA-corp.d98.s9.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	Together, the coordinated application of miRNA profiling, Affymetrix microarrays, new bioinformatics predictions, in situ hybridization, and biochemical validation indicate that <e1>miR-107</e1> may be involved in accelerated disease progression through regulation of <e2>BACE1</e2>.
miRNA-corp.d98.s10.p1	MIR_GENE	NEU	FALSE	FALSE	FALSE	The expression of microRNA <e1>miR-107</e1> decreases early in Alzheimer's disease and may accelerate disease progression through regulation of <e2>beta-site amyloid precursor protein-cleaving enzyme 1</e2>.
miRNA-corp.d102.s0.p0	NA	NA	FALSE	FALSE	FALSE	<e1>MicroRNA-205</e1> inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1.  <e2>Low-density lipoprotein receptor-related protein 1</e2> (LRP1) is a multifunctional endocytic receptor that plays critical roles in the pathogenesis of several human diseases including tumor metastasis and Alzheimer's disease.
miRNA-corp.d102.s0.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	<e1>MicroRNA-205</e1> inhibits tumor cell migration through down-regulating the expression of the <e2>LDL receptor-related protein 1</e2>.  Low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional endocytic receptor that plays critical roles in the pathogenesis of several human diseases including tumor metastasis and Alzheimer's disease.
miRNA-corp.d102.s0.p2	NA	NA	FALSE	FALSE	FALSE	<e1>MicroRNA-205</e1> inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1.  Low-density lipoprotein receptor-related protein 1 (<e2>LRP1</e2>) is a multifunctional endocytic receptor that plays critical roles in the pathogenesis of several human diseases including tumor metastasis and Alzheimer's disease.
miRNA-corp.d102.s1.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In human cell lines, we found that <e1>miR-205</e1> down-regulates the expression of <e2>LRP1</e2> by targeting sequences in the 3'UTR of LRP1 mRNA.
miRNA-corp.d102.s1.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	In human cell lines, we found that <e1>miR-205</e1> down-regulates the expression of LRP1 by targeting sequences in the 3'UTR of <e2>LRP1</e2> mRNA.
miRNA-corp.d102.s4.p0	NA	NA	FALSE	FALSE	FALSE	This effect was abolished by deleting the <e1>miR-205</e1> seed site in the 3'UTR of <e2>LRP1</e2>.
miRNA-corp.d107.s0.p0	MIR_GENE	DOWN	TRUE	FALSE	FALSE	Loss of microRNA cluster <e1>miR-29a/b-1</e1> in sporadic Alzheimer's disease correlates with increased <e2>BACE1</e2>/beta-secretase expression.
miRNA-corp.d107.s0.p2	MIR_GENE	DOWN	TRUE	FALSE	FALSE	Loss of microRNA cluster <e1>miR-29a/b-1</e1> in sporadic Alzheimer's disease correlates with increased BACE1/<e2>beta-secretase</e2> expression.
miRNA-corp.d107.s3.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	We show here that <e1>miR-29a, -29b-1, and -9</e1> can regulate <e2>BACE1</e2> expression in vitro.
miRNA-corp.d107.s4.p3	MIR_GENE	DOWN	TRUE	FALSE	FALSE	The <e1>miR-29a/b-1</e1> cluster was significantly (and AD-dementia-specific) decreased in AD patients displaying abnormally high <e2>BACE1</e2> protein.
miRNA-corp.d107.s6.p0	NA	NA	FALSE	FALSE	FALSE	Finally, we provide evidence for a potential causal relationship between <e1>miR-29a/b-1</e1> expression and <e2>Abeta</e2> generation in a cell culture model.
miRNA-corp.d108.s0.p1	NA	NA	FALSE	FALSE	FALSE	Here we expand the role of <e2>GRN</e2> in FTLD-U and demonstrate that a common genetic variant (rs5848), located in the 3'-untranslated region (UTR) of GRN in a binding-site for <e1>miR-659</e1>, is a major susceptibility factor for FTLD-U.
miRNA-corp.d108.s0.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Here we expand the role of GRN in FTLD-U and demonstrate that a common genetic variant (rs5848), located in the 3'-untranslated region (UTR) of <e2>GRN</e2> in a binding-site for <e1>miR-659</e1>, is a major susceptibility factor for FTLD-U.
miRNA-corp.d108.s2.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Common variation in the <e1>miR-659</e1> binding-site of <e2>GRN</e2> is a major risk factor for TDP43-positive frontotemporal dementia.
miRNA-corp.d108.s2.p2	NA	NA	FALSE	FALSE	FALSE	Common variation in the <e1>miR-659</e1> binding-site of GRN is a major risk factor for <e2>TDP43</e2>-positive frontotemporal dementia.
miRNA-corp.d108.s5.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	We further demonstrate that miR-659 can regulate GRN expression in vitro, with <e1>miR-659</e1> binding more efficiently to the high risk T-allele of rs5848 resulting in augmented translational inhibition of <e2>GRN</e2>.
miRNA-corp.d108.s5.p1	NA	NA	FALSE	FALSE	FALSE	We further demonstrate that miR-659 can regulate <e2>GRN</e2> expression in vitro, with <e1>miR-659</e1> binding more efficiently to the high risk T-allele of rs5848 resulting in augmented translational inhibition of GRN.
miRNA-corp.d108.s5.p2	NA	NA	FALSE	FALSE	FALSE	We further demonstrate that <e1>miR-659</e1> can regulate GRN expression in vitro, with miR-659 binding more efficiently to the high risk T-allele of rs5848 resulting in augmented translational inhibition of <e2>GRN</e2>.
miRNA-corp.d108.s5.p3	MIR_GENE	NEU	FALSE	FALSE	FALSE	We further demonstrate that <e1>miR-659</e1> can regulate <e2>GRN</e2> expression in vitro, with miR-659 binding more efficiently to the high risk T-allele of rs5848 resulting in augmented translational inhibition of GRN.
miRNA-corp.d109.s2.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	We further showed that CCNE1 (encoding <e2>cyclin E1</e2>) is one of the downstream targets of <e1>miR-15b</e1>.
miRNA-corp.d109.s2.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	We further showed that <e2>CCNE1</e2> (encoding cyclin E1) is one of the downstream targets of <e1>miR-15b</e1>.
miRNA-corp.d112.s7.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Further, irradiation significantly altered expression of <e1>miR-194</e1>, a miRNA putatively targeting both DNA methyltransferase-3a and <e2>MeCP2</e2>.
miRNA-corp.d114.s1.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Here we provide evidence in human neural (HN) cells of an aluminum-sulfate- and reactive oxygen species (ROS)-mediated up-regulation of an NF-kappaB-sensitive <e1>miRNA-146a</e1> that down-regulates the expression of <e2>complement factor H</e2> (CFH), an important repressor of inflammation.
miRNA-corp.d114.s1.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Here we provide evidence in human neural (HN) cells of an aluminum-sulfate- and reactive oxygen species (ROS)-mediated up-regulation of an NF-kappaB-sensitive <e1>miRNA-146a</e1> that down-regulates the expression of complement factor H (<e2>CFH</e2>), an important repressor of inflammation.
miRNA-corp.d114.s2.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Characterization of an NF-kappaB-regulated, <e1>miRNA-146a</e1>-mediated down-regulation of <e2>complement factor H</e2> (CFH) in metal-sulfate-stressed human brain cells.
miRNA-corp.d114.s2.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Characterization of an NF-kappaB-regulated, <e1>miRNA-146a</e1>-mediated down-regulation of complement factor H (<e2>CFH</e2>) in metal-sulfate-stressed human brain cells.
miRNA-corp.d114.s4.p0	NA	NA	FALSE	FALSE	FALSE	An NF-kappaB-containing <e1>miRNA-146a</e1>-promoter-luciferase reporter construct transfected into HN cells showed significant up-regulation of miRNA-146a after aluminum-sulfate treatment that corresponded to decreased <e2>CFH</e2> gene expression.
miRNA-corp.d114.s4.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	An NF-kappaB-containing miRNA-146a-promoter-luciferase reporter construct transfected into HN cells showed significant up-regulation of <e1>miRNA-146a</e1> after aluminum-sulfate treatment that corresponded to decreased <e2>CFH</e2> gene expression.
miRNA-corp.d114.s5.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	These data suggest that (1) as in AD brain, NF-kappaB-sensitive, <e1>miRNA-146a</e1>-mediated, modulation of <e2>CFH</e2> gene expression may contribute to inflammatory responses in aluminum-stressed HN cells, and (2) underscores the potential of nanomolar aluminum to drive genotoxic mechanisms characteristic of neurodegenerative disease processes.
miRNA-corp.d114.s6.p0	NA	NA	FALSE	FALSE	FALSE	This NF-kappaB-<e1>miRNA-146a</e1>-CFH signaling circuit is known to be similarly affected by <e2>Abeta42</e2> peptides and in AD brain.
miRNA-corp.d114.s6.p1	NA	NA	FALSE	FALSE	FALSE	This NF-kappaB-<e1>miRNA-146a</e1>-<e2>CFH</e2> signaling circuit is known to be similarly affected by Abeta42 peptides and in AD brain.
miRNA-corp.d116.s0.p0	NA	NA	FALSE	FALSE	FALSE	Pharmacologic and genetic inhibition of p53 corroborated the hypothesis that pre-<e1>miR-630</e1> (but not pre-miR-181a) blocks the upstream signaling pathways that are ignited by DNA damage and converge on <e2>p53</e2> activation.
miRNA-corp.d116.s0.p1	NA	NA	FALSE	FALSE	FALSE	Pharmacologic and genetic inhibition of <e2>p53</e2> corroborated the hypothesis that pre-<e1>miR-630</e1> (but not pre-miR-181a) blocks the upstream signaling pathways that are ignited by DNA damage and converge on p53 activation.
miRNA-corp.d116.s0.p3	NA	NA	FALSE	FALSE	FALSE	Pharmacologic and genetic inhibition of p53 corroborated the hypothesis that pre-miR-630 (but not pre-<e1>miR-181a</e1>) blocks the upstream signaling pathways that are ignited by DNA damage and converge on <e2>p53</e2> activation.
miRNA-corp.d116.s0.p4	NA	NA	FALSE	FALSE	FALSE	Pharmacologic and genetic inhibition of <e2>p53</e2> corroborated the hypothesis that pre-miR-630 (but not pre-<e1>miR-181a</e1>) blocks the upstream signaling pathways that are ignited by DNA damage and converge on p53 activation.
miRNA-corp.d116.s1.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Pre-<e1>miR-630</e1> arrested A549 cells in the G0-G1 phase of the cell cycle, correlating with increased levels of the cell cycle inhibitor <e2>p27</e2>(Kip1) as well as with reduced proliferation rates and resulting in greatly diminished sensitivity of A549 cells to the late S-G2-M cell cycle arrest mediated by CDDP.
miRNA-corp.d116.s1.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Pre-<e1>miR-630</e1> arrested A549 cells in the G0-G1 phase of the cell cycle, correlating with increased levels of the cell cycle inhibitor p27(<e2>Kip1</e2>) as well as with reduced proliferation rates and resulting in greatly diminished sensitivity of A549 cells to the late S-G2-M cell cycle arrest mediated by CDDP.
miRNA-corp.d116.s5.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	Pre-<e1>miR-181a</e1> and pre-miR-630 consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including Bax oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of <e2>caspase-9</e2> and caspase-3.
miRNA-corp.d116.s5.p1	MIR_GENE	NEU	FALSE	FALSE	FALSE	Pre-<e1>miR-181a</e1> and pre-miR-630 consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including Bax oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of caspase-9 and <e2>caspase-3</e2>.
miRNA-corp.d116.s5.p2	MIR_GENE	NEU	FALSE	FALSE	FALSE	Pre-<e1>miR-181a</e1> and pre-miR-630 consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including <e2>Bax</e2> oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of caspase-9 and caspase-3.
miRNA-corp.d116.s5.p3	MIR_GENE	NEU	FALSE	FALSE	FALSE	Pre-miR-181a and pre-<e1>miR-630</e1> consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including Bax oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of <e2>caspase-9</e2> and caspase-3.
miRNA-corp.d116.s5.p4	MIR_GENE	NEU	FALSE	FALSE	FALSE	Pre-miR-181a and pre-<e1>miR-630</e1> consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including Bax oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of caspase-9 and <e2>caspase-3</e2>.
miRNA-corp.d116.s5.p5	MIR_GENE	NEU	FALSE	FALSE	FALSE	Pre-miR-181a and pre-<e1>miR-630</e1> consistently modulated mitochondrial/postmitochondrial steps of the intrinsic pathway of apoptosis, including <e2>Bax</e2> oligomerization, mitochondrial transmembrane potential dissipation, and the proteolytic maturation of caspase-9 and caspase-3.
miRNA-corp.d116.s6.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In addition, pre-<e1>miR-630</e1> blocked early manifestations of the DNA damage response, including the phosphorylation of the <e2>ataxia-telangiectasia mutated</e2> (ATM) kinase and of two ATM substrates, histone H2AX and p53.
miRNA-corp.d116.s6.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In addition, pre-<e1>miR-630</e1> blocked early manifestations of the DNA damage response, including the phosphorylation of the ataxia-telangiectasia mutated (<e2>ATM</e2>) kinase and of two ATM substrates, histone H2AX and p53.
miRNA-corp.d116.s6.p2	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In addition, pre-<e1>miR-630</e1> blocked early manifestations of the DNA damage response, including the phosphorylation of the ataxia-telangiectasia mutated (ATM) kinase and of two <e2>ATM</e2> substrates, histone H2AX and p53.
miRNA-corp.d116.s6.p3	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In addition, pre-<e1>miR-630</e1> blocked early manifestations of the DNA damage response, including the phosphorylation of the ataxia-telangiectasia mutated (ATM) kinase and of two ATM substrates, histone <e2>H2AX</e2> and p53.
miRNA-corp.d116.s6.p4	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In addition, pre-<e1>miR-630</e1> blocked early manifestations of the DNA damage response, including the phosphorylation of the ataxia-telangiectasia mutated (ATM) kinase and of two ATM substrates, histone H2AX and <e2>p53</e2>.
miRNA-corp.d118.s0.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, <e1>miR-155</e1>, and miR-516a-3p) targeted the 3'-untranslated region of the <e2>Wee1</e2> transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.
miRNA-corp.d118.s0.p1	NA	NA	FALSE	FALSE	FALSE	A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, <e1>miR-155</e1>, and miR-516a-3p) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these miRs inhibited <e2>Wee1</e2> protein expression and HeLa cell proliferation.
miRNA-corp.d118.s0.p8	MIR_GENE	TARGET	FALSE	FALSE	FALSE	A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, miR-155, and <e1>miR-516a-3p</e1>) targeted the 3'-untranslated region of the <e2>Wee1</e2> transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.
miRNA-corp.d118.s0.p9	NA	NA	FALSE	FALSE	FALSE	A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, miR-155, and <e1>miR-516a-3p</e1>) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these miRs inhibited <e2>Wee1</e2> protein expression and HeLa cell proliferation.
miRNA-corp.d118.s0.p10	MIR_GENE	TARGET	FALSE	FALSE	FALSE	A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (<e1>miR-128a</e1>, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the <e2>Wee1</e2> transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.
miRNA-corp.d118.s0.p11	NA	NA	FALSE	FALSE	FALSE	A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (<e1>miR-128a</e1>, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these miRs inhibited <e2>Wee1</e2> protein expression and HeLa cell proliferation.
miRNA-corp.d122.s4.p3	NA	NA	FALSE	FALSE	FALSE	However, no studies have investigated the clinical significance of <e2>high-mobility group A2</e2> and its relationship to the <e1>let-7</e1> miRNA family in human pituitary adenomas.
miRNA-corp.d122.s6.p0	NA	NA	FALSE	FALSE	FALSE	Recent studies report that <e2>high-mobility group A2</e2> is negatively regulated by the <e1>let-7</e1> microRNAs (miRNAs) family in vitro.
miRNA-corp.d122.s8.p0	MIR_GENE	DOWN	TRUE	FALSE	FALSE	Overexpression of <e2>HMGA2</e2> relates to reduction of the <e1>let-7</e1> and its relationship to clinicopathological features in pituitary adenomas.
miRNA-corp.d122.s12.p0	MIR_GENE	DOWN	TRUE	FALSE	FALSE	An inverse correlation between <e1>let-7</e1> and <e2>high-mobility group A2</e2> expression was evident (R=-0.33, P<0.05).
miRNA-corp.d122.s13.p0	NA	NA	FALSE	FALSE	FALSE	These findings support a causal link between <e1>let-7</e1> and high-mobility group A2 whereby loss of let-7 expression induces <e2>high-mobility group A2</e2> upregulation that represents an important mechanism in pituitary tumorigenesis and progression.
miRNA-corp.d122.s13.p1	MIR_GENE	NEU	FALSE	FALSE	FALSE	These findings support a causal link between <e1>let-7</e1> and <e2>high-mobility group A2</e2> whereby loss of let-7 expression induces high-mobility group A2 upregulation that represents an important mechanism in pituitary tumorigenesis and progression.
miRNA-corp.d122.s13.p2	MIR_GENE	DOWN	TRUE	FALSE	FALSE	These findings support a causal link between let-7 and high-mobility group A2 whereby loss of <e1>let-7</e1> expression induces <e2>high-mobility group A2</e2> upregulation that represents an important mechanism in pituitary tumorigenesis and progression.
miRNA-corp.d122.s13.p3	NA	NA	FALSE	FALSE	FALSE	These findings support a causal link between let-7 and <e2>high-mobility group A2</e2> whereby loss of <e1>let-7</e1> expression induces high-mobility group A2 upregulation that represents an important mechanism in pituitary tumorigenesis and progression.
miRNA-corp.d132.s0.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Moreover, LPS stimulation decreased expression of microRNAs (miRNA)--miR-17-5, miR-20a, and <e1>miR-93</e1>--which target <e2>MICA</e2>, implicating a novel role for miRNAs in NKG2D ligand expression.
miRNA-corp.d132.s0.p4	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Moreover, LPS stimulation decreased expression of microRNAs (miRNA)--<e1>miR-17-5</e1>, miR-20a, and miR-93--which target <e2>MICA</e2>, implicating a novel role for miRNAs in NKG2D ligand expression.
miRNA-corp.d132.s0.p5	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Moreover, LPS stimulation decreased expression of microRNAs (miRNA)--miR-17-5, <e1>miR-20a</e1>, and miR-93--which target <e2>MICA</e2>, implicating a novel role for miRNAs in NKG2D ligand expression.
miRNA-corp.d134.s0.p0	NA	NA	FALSE	FALSE	FALSE	Our in vitro results suggested that Aβ42 oligomer-induced <e1>miR-106b</e1> leads to impairment in TGF-β signaling through <e2>TβR II</e2>, concomitant with retinoic acid-induced neurodegeneration in SH-SY5Y cells.
miRNA-corp.d134.s0.p1	NA	NA	FALSE	FALSE	FALSE	Our in vitro results suggested that Aβ42 oligomer-induced <e1>miR-106b</e1> leads to impairment in <e2>TGF-β</e2> signaling through TβR II, concomitant with retinoic acid-induced neurodegeneration in SH-SY5Y cells.
miRNA-corp.d134.s1.p0	NA	NA	FALSE	FALSE	FALSE	These results show that <e2>TβR II</e2> is a functional target of miR-106b and that <e1>miR-106b</e1> may influence TGF-β signaling, thereby contributing to the pathogenesis of AD.
miRNA-corp.d134.s1.p2	NA	NA	FALSE	FALSE	FALSE	These results show that TβR II is a functional target of miR-106b and that <e1>miR-106b</e1> may influence <e2>TGF-β</e2> signaling, thereby contributing to the pathogenesis of AD.
miRNA-corp.d134.s1.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	These results show that <e2>TβR II</e2> is a functional target of <e1>miR-106b</e1> and that miR-106b may influence TGF-β signaling, thereby contributing to the pathogenesis of AD.
miRNA-corp.d134.s1.p5	NA	NA	FALSE	FALSE	FALSE	These results show that TβR II is a functional target of <e1>miR-106b</e1> and that miR-106b may influence <e2>TGF-β</e2> signaling, thereby contributing to the pathogenesis of AD.
miRNA-corp.d134.s3.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	<e1>miR-106b</e1> aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets <e2>TGF-β type II receptor</e2>.
miRNA-corp.d134.s6.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Sequence analysis revealed two putative binding sites for <e1>miR-106b</e1> in the 3' UTR of the <e2>TβR II</e2> mRNA.
miRNA-corp.d134.s7.p1	NA	NA	FALSE	FALSE	FALSE	Here we found that <e1>miR-106b</e1> and <e2>TGF-β type II receptor</e2> (TβR II) were aberrantly expressed in APPswe/PS∆E9 mice (a double transgenic mouse model for AD).
miRNA-corp.d134.s7.p2	NA	NA	FALSE	FALSE	FALSE	Here we found that <e1>miR-106b</e1> and TGF-β type II receptor (<e2>TβR II</e2>) were aberrantly expressed in APPswe/PS∆E9 mice (a double transgenic mouse model for AD).
miRNA-corp.d134.s9.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Our results showed that the expression of <e1>miR-106b</e1> was inversely correlated with <e2>TβR II</e2> protein levels and miR-106b can directly inhibit the TβR II translation in vitro.
miRNA-corp.d134.s9.p1	NA	NA	FALSE	FALSE	FALSE	Our results showed that the expression of <e1>miR-106b</e1> was inversely correlated with TβR II protein levels and miR-106b can directly inhibit the <e2>TβR II</e2> translation in vitro.
miRNA-corp.d134.s9.p2	NA	NA	FALSE	FALSE	FALSE	Our results showed that the expression of miR-106b was inversely correlated with <e2>TβR II</e2> protein levels and <e1>miR-106b</e1> can directly inhibit the TβR II translation in vitro.
miRNA-corp.d134.s9.p3	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Our results showed that the expression of miR-106b was inversely correlated with TβR II protein levels and <e1>miR-106b</e1> can directly inhibit the <e2>TβR II</e2> translation in vitro.
miRNA-corp.d134.s10.p0	NA	NA	FALSE	FALSE	FALSE	Exposure of SH-SY5Y cells to Aβ42 oligomers led to the expression of <e1>miR-106b</e1> was first increased and then decreased and <e2>TβR II</e2> levels reduced.
miRNA-corp.d134.s11.p0	NA	NA	FALSE	FALSE	FALSE	Western blot analysis revealed unchanged total Smad2/3 protein levels, but reduced <e2>phospho-Smad2/3</e2> (p-Smad2/3) and increased Smad6/7 protein levels in the <e1>miR-106b</e1> stably transfected cell line.
miRNA-corp.d134.s11.p1	NA	NA	FALSE	FALSE	FALSE	Western blot analysis revealed unchanged total Smad2/3 protein levels, but reduced phospho-Smad2/3 (<e2>p-Smad2/3</e2>) and increased Smad6/7 protein levels in the <e1>miR-106b</e1> stably transfected cell line.
miRNA-corp.d134.s11.p2	NA	NA	FALSE	FALSE	FALSE	Western blot analysis revealed unchanged total <e2>Smad2/3</e2> protein levels, but reduced phospho-Smad2/3 (p-Smad2/3) and increased Smad6/7 protein levels in the <e1>miR-106b</e1> stably transfected cell line.
miRNA-corp.d134.s11.p3	MIR_GENE	UP	FALSE	FALSE	FALSE	Western blot analysis revealed unchanged total Smad2/3 protein levels, but reduced phospho-Smad2/3 (p-Smad2/3) and increased <e2>Smad6/7</e2> protein levels in the <e1>miR-106b</e1> stably transfected cell line.
miRNA-corp.d135.s6.p2	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Interestingly, both miRNAs are capable of binding directly to <e2>TDP-43</e2> in different positions: within the miRNA sequence itself (<e1>let-7b</e1>) or in the hairpin precursor (miR-663).
miRNA-corp.d135.s6.p3	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Interestingly, both miRNAs are capable of binding directly to <e2>TDP-43</e2> in different positions: within the miRNA sequence itself (let-7b) or in the hairpin precursor (<e1>miR-663</e1>).
miRNA-corp.d142.s4.p0	NA	NA	FALSE	FALSE	FALSE	Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (<e1>miR-298</e1> and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (<e2>APP</e2>)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.
miRNA-corp.d142.s4.p3	NA	NA	FALSE	FALSE	FALSE	Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (<e1>miR-298</e1> and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying <e2>BACE</e2> deregulation in AD.
miRNA-corp.d142.s4.p4	MIR_GENE	NEU	FALSE	FALSE	FALSE	Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (<e1>miR-298</e1> and miR-328) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (<e2>BACE</e2>) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.
miRNA-corp.d142.s4.p5	MIR_GENE	NEU	FALSE	FALSE	FALSE	Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (<e1>miR-298</e1> and miR-328) in the regulation of <e2>beta-amyloid (Abeta) precursor protein (APP)-converting enzyme</e2> (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.
miRNA-corp.d142.s4.p6	NA	NA	FALSE	FALSE	FALSE	Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and <e1>miR-328</e1>) in the regulation of beta-amyloid (Abeta) precursor protein (<e2>APP</e2>)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.
miRNA-corp.d142.s4.p9	NA	NA	FALSE	FALSE	FALSE	Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and <e1>miR-328</e1>) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying <e2>BACE</e2> deregulation in AD.
miRNA-corp.d142.s4.p10	MIR_GENE	NEU	FALSE	FALSE	FALSE	Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and <e1>miR-328</e1>) in the regulation of beta-amyloid (Abeta) precursor protein (APP)-converting enzyme (<e2>BACE</e2>) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.
miRNA-corp.d142.s4.p11	MIR_GENE	NEU	FALSE	FALSE	FALSE	Using transiently transfected murine neuronal N2a cells in culture, in parallel to a mouse model of AD, we were able to demonstrate a role for two miRNAs (miR-298 and <e1>miR-328</e1>) in the regulation of <e2>beta-amyloid (Abeta) precursor protein (APP)-converting enzyme</e2> (BACE) messenger RNA (mRNA) translation, thereby providing key insights into the molecular basis underlying BACE deregulation in AD.
miRNA-corp.d144.s2.p0	NA	NA	FALSE	FALSE	FALSE	Up-regulation of <e1>miRNA-146a</e1> coupled to down-regulation of CFH was observed in AD brain and in <e2>interleukin-1beta</e2>, Abeta42, and/or oxidatively stressed human neural (HN) cells in primary culture.
miRNA-corp.d144.s2.p1	NA	NA	FALSE	FALSE	FALSE	Up-regulation of <e1>miRNA-146a</e1> coupled to down-regulation of CFH was observed in AD brain and in interleukin-1beta, <e2>Abeta42</e2>, and/or oxidatively stressed human neural (HN) cells in primary culture.
miRNA-corp.d144.s2.p2	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Up-regulation of <e1>miRNA-146a</e1> coupled to down-regulation of <e2>CFH</e2> was observed in AD brain and in interleukin-1beta, Abeta42, and/or oxidatively stressed human neural (HN) cells in primary culture.
miRNA-corp.d144.s3.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Here we provide evidence in AD brains of a specific up-regulation of an NF-kappaB-sensitive <e1>miRNA-146a</e1> highly complementary to the 3'-untranslated region of <e2>complement factor H </e2>(CFH), an important repressor of the inflammatory response of the brain.
miRNA-corp.d144.s3.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Here we provide evidence in AD brains of a specific up-regulation of an NF-kappaB-sensitive <e1>miRNA-146a</e1> highly complementary to the 3'-untranslated region of complement factor H (<e2>CFH</e2>), an important repressor of the inflammatory response of the brain.
miRNA-corp.d144.s5.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Transfection of HN cells using an NF-kappaB-containing pre-<e1>miRNA-146a</e1> promoter-luciferase reporter construct in stressed HN cells showed significant up-regulation of luciferase activity that paralleled decreases in <e2>CFH</e2> gene expression.
miRNA-corp.d144.s7.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	These data indicate that NF-kappaB-sensitive <e1>miRNA-146a</e1>-mediated modulation of <e2>CFH</e2> gene expression may in part regulate an inflammatory response in AD brain and in stressed HN cell models of AD and illustrate the potential for anti-miRNAs as an effective therapeutic strategy against pathogenic inflammatory signaling.
miRNA-corp.d153.s6.p2	NA	NA	FALSE	FALSE	FALSE	We further demonstrate that miRNAs belonging to the <e1>miR-15</e1> family are potent regulators of ERK1 expression in mouse neuronal cells and co-expressed with <e2>ERK1/2</e2> in vivo.
miRNA-corp.d153.s6.p3	NA	NA	FALSE	FALSE	FALSE	We further demonstrate that miRNAs belonging to the <e1>miR-15</e1> family are potent regulators of <e2>ERK1</e2> expression in mouse neuronal cells and co-expressed with ERK1/2 in vivo.
miRNA-corp.d154.s2.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Furthermore, we show that <e1>miR-21</e1> specifically targets the mRNA of <e2>myocyte enhancer factor 2C</e2> (MEF2C), a transcription factor crucial for neuronal function, and reduces its expression.
miRNA-corp.d154.s2.p1	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Furthermore, we show that <e1>miR-21</e1> specifically targets the mRNA of myocyte enhancer factor 2C (<e2>MEF2C</e2>), a transcription factor crucial for neuronal function, and reduces its expression.
miRNA-corp.d154.s6.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	<e1>MicroRNA-21</e1> dysregulates the expression of <e2>MEF2C</e2> in neurons in monkey and human SIV/HIV neurological disease.
miRNA-corp.d156.s8.p0	NA	NA	FALSE	FALSE	FALSE	Our analysis revealed <e2>EGR3</e2> and <e1>hsa-miR-195</e1> were core regulators in this regulatory network.
miRNA-corp.d157.s0.p1	NA	NA	FALSE	FALSE	FALSE	METHODOLOGY/PRINCIPAL FINDINGS; In a screening of MB cell lines, the miRNA miR-199b-5p was seen to be a regulator of the Notch pathway through its targeting of the transcription factor <e2>HES1</e2>. Down-regulation of HES1 expression by <e1>miR-199b-5p</e1> negatively regulates the proliferation rate and anchorage-independent growth of MB cells.
miRNA-corp.d157.s0.p2	MIR_GENE	DOWN	TRUE	FALSE	FALSE	METHODOLOGY/PRINCIPAL FINDINGS; In a screening of MB cell lines, the miRNA miR-199b-5p was seen to be a regulator of the Notch pathway through its targeting of the transcription factor HES1. Down-regulation of <e2>HES1</e2> expression by <e1>miR-199b-5p</e1> negatively regulates the proliferation rate and anchorage-independent growth of MB cells.
miRNA-corp.d157.s0.p7	MIR_GENE	TARGET	FALSE	FALSE	FALSE	METHODOLOGY/PRINCIPAL FINDINGS; In a screening of MB cell lines, the miRNA <e1>miR-199b-5p</e1> was seen to be a regulator of the Notch pathway through its targeting of the transcription factor <e2>HES1</e2>. Down-regulation of HES1 expression by miR-199b-5p negatively regulates the proliferation rate and anchorage-independent growth of MB cells.
miRNA-corp.d157.s0.p8	NA	NA	FALSE	FALSE	FALSE	METHODOLOGY/PRINCIPAL FINDINGS; In a screening of MB cell lines, the miRNA <e1>miR-199b-5p</e1> was seen to be a regulator of the Notch pathway through its targeting of the transcription factor HES1. Down-regulation of <e2>HES1</e2> expression by miR-199b-5p negatively regulates the proliferation rate and anchorage-independent growth of MB cells.
miRNA-corp.d157.s9.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	<e1>MicroRNA-199b-5p</e1> impairs cancer stem cells through negative regulation of <e2>HES1</e2> in medulloblastoma.
miRNA-corp.d161.s0.p1	NA	NA	FALSE	FALSE	FALSE	Our findings suggest a functional collaboration between the <e1>miR-17</e1> approximately 92 cluster and the <e2>SHH</e2> signaling pathway in the development of MBs in mouse and man.
miRNA-corp.d161.s1.p2	NA	NA	FALSE	FALSE	FALSE	Analysis of human MBs demonstrated that 3 <e1>miR-17</e1> approximately 92 cluster miRNAs (miR-92, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated <e2>Sonic Hedgehog</e2> (SHH) signaling pathway, but not in other forms of the disease.
miRNA-corp.d161.s1.p3	NA	NA	FALSE	FALSE	FALSE	Analysis of human MBs demonstrated that 3 <e1>miR-17</e1> approximately 92 cluster miRNAs (miR-92, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (<e2>SHH</e2>) signaling pathway, but not in other forms of the disease.
miRNA-corp.d161.s1.p6	NA	NA	FALSE	FALSE	FALSE	Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (<e1>miR-92</e1>, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated <e2>Sonic Hedgehog</e2> (SHH) signaling pathway, but not in other forms of the disease.
miRNA-corp.d161.s1.p7	NA	NA	FALSE	FALSE	FALSE	Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (<e1>miR-92</e1>, miR-19a, and miR-20) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (<e2>SHH</e2>) signaling pathway, but not in other forms of the disease.
miRNA-corp.d161.s1.p10	NA	NA	FALSE	FALSE	FALSE	Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, <e1>miR-19a</e1>, and miR-20) were also overexpressed in human MBs with a constitutively activated <e2>Sonic Hedgehog</e2> (SHH) signaling pathway, but not in other forms of the disease.
miRNA-corp.d161.s1.p11	NA	NA	FALSE	FALSE	FALSE	Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, <e1>miR-19a</e1>, and miR-20) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (<e2>SHH</e2>) signaling pathway, but not in other forms of the disease.
miRNA-corp.d161.s1.p18	NA	NA	FALSE	FALSE	FALSE	Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, miR-19a, and <e1>miR-20</e1>) were also overexpressed in human MBs with a constitutively activated <e2>Sonic Hedgehog</e2> (SHH) signaling pathway, but not in other forms of the disease.
miRNA-corp.d161.s1.p19	NA	NA	FALSE	FALSE	FALSE	Analysis of human MBs demonstrated that 3 miR-17 approximately 92 cluster miRNAs (miR-92, miR-19a, and <e1>miR-20</e1>) were also overexpressed in human MBs with a constitutively activated Sonic Hedgehog (<e2>SHH</e2>) signaling pathway, but not in other forms of the disease.
miRNA-corp.d161.s2.p3	NA	NA	FALSE	FALSE	FALSE	To test whether the <e1>miR-17</e1> approximately 92 cluster could promote MB formation, we enforced expression of these miRNAs in GNPs isolated from cerebella of postnatal (P) day P6 <e2>Ink4c</e2>-/-.;  Ptch1+/- mice. 
miRNA-corp.d161.s4.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Interestingly, orthotopic mouse tumors ectopically expressing <e1>miR-17</e1> approximately 92 lost expression of the wild-type <e2>Ptch1</e2> allele.
miRNA-corp.d161.s9.p1	NA	NA	FALSE	FALSE	FALSE	The <e1>miR-17~92</e1> cluster collaborates with the <e2>Sonic Hedgehog</e2> pathway in medulloblastoma.
miRNA-corp.d169.s0.p4	NA	NA	FALSE	FALSE	FALSE	MicroRNA expression in <e2>ACTH</e2>-producing pituitary tumors: up-regulation of <e1>microRNA-122 and -493</e1> in pituitary carcinomas.
miRNA-corp.d169.s5.p0	NA	NA	FALSE	FALSE	FALSE	<e1>MiRNA-493</e1> was also up-regulated in carcinomas compared to <e2>ACTH</e2> adenomas.
miRNA-corp.d169.s6.p1	MIR_GENE	NEU	FALSE	FALSE	FALSE	Analysis of genes that <e1>miRNA-493</e1> interacts with included <e2>LGALS3</e2> and RUNX2 ( http://microrna.sanger.ac.uk ) both of which have been shown to have roles in pituitary tumor cell growth.
miRNA-corp.d169.s6.p2	MIR_GENE	NEU	FALSE	FALSE	FALSE	Analysis of genes that <e1>miRNA-493</e1> interacts with included LGALS3 and <e2>RUNX2</e2> ( http://microrna.sanger.ac.uk ) both of which have been shown to have roles in pituitary tumor cell growth.
miRNA-corp.d172.s5.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	<e1>miR-133b</e1> targets the small GTPase <e2>RhoA</e2>, which is an inhibitor of axonal growth, as well as other neurite outgrowth-related molecules.
miRNA-corp.d172.s6.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Our results indicate that <e1>miR-133b</e1> is an important determinant in spinal cord regeneration of adult zebrafish through reduction in <e2>RhoA</e2> protein levels by direct interaction with its mRNA.
miRNA-corp.d175.s6.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	We show that miRNAs belonging to the miR-20a family (that is, <e1>miR-20a</e1>, miR-17-5p and miR-106b) could regulate <e2>APP</e2> expression in vitro and at the endogenous level in neuronal cell lines.
miRNA-corp.d175.s6.p1	MIR_GENE	NEU	FALSE	FALSE	FALSE	We show that miRNAs belonging to the miR-20a family (that is, miR-20a, <e1>miR-17-5p</e1> and miR-106b) could regulate <e2>APP</e2> expression in vitro and at the endogenous level in neuronal cell lines.
miRNA-corp.d175.s6.p2	MIR_GENE	NEU	FALSE	FALSE	FALSE	We show that miRNAs belonging to the miR-20a family (that is, miR-20a, miR-17-5p and <e1>miR-106b</e1>) could regulate <e2>APP</e2> expression in vitro and at the endogenous level in neuronal cell lines.
miRNA-corp.d175.s6.p4	NA	NA	FALSE	FALSE	FALSE	We show that miRNAs belonging to the <e1>miR-20a</e1> family (that is, miR-20a, miR-17-5p and miR-106b) could regulate <e2>APP</e2> expression in vitro and at the endogenous level in neuronal cell lines.
miRNA-corp.d176.s1.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	A known <e1>miRNA-146a</e1> target in the brain, <e2>complement factor H</e2>, was downregulated.
miRNA-corp.d178.s1.p4	GENE_MIR	NEU	FALSE	FALSE	FALSE	Because of its known connection to glioma biology, we focused on <e1>miR-21</e1> among seven miRNAs influenced by <e2>IFN-beta</e2>.
miRNA-corp.d178.s4.p0	NA	NA	FALSE	FALSE	FALSE	The levels of primary miR-21 gene transcripts, precursor miR-21, and mature miR-21 decreased 6 hours after the addition of <e2>IFN-beta</e2>, indicating that the reduction in <e1>miR-21</e1> levels was due to transcriptional suppression.
miRNA-corp.d178.s4.p1	GENE_MIR	DOWN	FALSE	FALSE	FALSE	The levels of primary miR-21 gene transcripts, precursor miR-21, and mature <e1>miR-21</e1> decreased 6 hours after the addition of <e2>IFN-beta</e2>, indicating that the reduction in miR-21 levels was due to transcriptional suppression.
miRNA-corp.d178.s4.p2	GENE_MIR	DOWN	FALSE	FALSE	FALSE	The levels of primary <e1>miR-21</e1> gene transcripts, precursor miR-21, and mature miR-21 decreased 6 hours after the addition of <e2>IFN-beta</e2>, indicating that the reduction in miR-21 levels was due to transcriptional suppression.
miRNA-corp.d178.s4.p3	GENE_MIR	DOWN	FALSE	FALSE	FALSE	The levels of primary miR-21 gene transcripts, precursor <e1>miR-21</e1>, and mature miR-21 decreased 6 hours after the addition of <e2>IFN-beta</e2>, indicating that the reduction in miR-21 levels was due to transcriptional suppression.
miRNA-corp.d178.s5.p0	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the <e2>IFN-beta</e2>-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the <e1>miR-21</e1> suppression.
miRNA-corp.d178.s5.p1	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the <e2>IFN-beta</e2>-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the <e1>miR-21</e1> suppression.
miRNA-corp.d178.s5.p2	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (<e2>STAT3</e2>)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the <e1>miR-21</e1> suppression.
miRNA-corp.d178.s5.p3	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of <e2>signal transducers and activators of transcription 3</e2> (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the <e1>miR-21</e1> suppression.
miRNA-corp.d178.s5.p4	GENE_MIR	DOWN	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the <e2>IFN-beta</e2>-mediated suppression of <e1>miR-21</e1>, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.
miRNA-corp.d178.s5.p5	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the <e2>IFN-beta</e2>-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of <e1>miR-21</e1>, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.
miRNA-corp.d178.s5.p6	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of signal transducers and activators of transcription 3 (<e2>STAT3</e2>)-expressing vectors induced the IFN-beta-mediated suppression of <e1>miR-21</e1>, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.
miRNA-corp.d178.s5.p7	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of miR-21; the addition of <e2>signal transducers and activators of transcription 3</e2> (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of <e1>miR-21</e1>, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.
miRNA-corp.d178.s5.p8	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of <e1>miR-21</e1>; the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the <e2>IFN-beta</e2>-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.
miRNA-corp.d178.s5.p9	GENE_MIR	DOWN	FALSE	FALSE	FALSE	We did reporter assays to elucidate the <e2>IFN-beta</e2>-mediated suppression of <e1>miR-21</e1>.;  the addition of signal transducers and activators of transcription 3 (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the miR-21 suppression. 
miRNA-corp.d178.s5.p10	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of <e1>miR-21</e1>; the addition of signal transducers and activators of transcription 3 (<e2>STAT3</e2>)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.
miRNA-corp.d178.s5.p11	NA	NA	FALSE	FALSE	FALSE	We did reporter assays to elucidate the IFN-beta-mediated suppression of <e1>miR-21</e1>; the addition of <e2>signal transducers and activators of transcription 3</e2> (STAT3)-expressing vectors induced the IFN-beta-mediated suppression of miR-21, whereas STAT3-inhibiting agents inhibited the miR-21 suppression.
miRNA-corp.d178.s6.p1	NA	NA	FALSE	FALSE	FALSE	We analyzed the effect of <e2>IFN-beta</e2> treatment on <e1>miR-21</e1> expression in glioma cells and intracranial glioma xenografts.
miRNA-corp.d178.s7.p0	GENE_MIR	DOWN	FALSE	FALSE	FALSE	<e2>IFN-beta</e2> treatment reduced <e1>miR-21</e1> expression in glioma cells markedly, and IFN-beta administration suppressed the growth of glioma-initiating cell-derived intracranial tumors.
miRNA-corp.d178.s7.p1	NA	NA	FALSE	FALSE	FALSE	IFN-beta treatment reduced <e1>miR-21</e1> expression in glioma cells markedly, and <e2>IFN-beta</e2> administration suppressed the growth of glioma-initiating cell-derived intracranial tumors.
miRNA-corp.d178.s8.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	Thus, the results of our study show that the downregulation of <e1>miR-21</e1> contributes to the antitumor effects of <e2>IFN-beta</e2> and that miR-21 expression is negatively regulated by STAT3 activation.
miRNA-corp.d178.s8.p1	NA	NA	FALSE	FALSE	FALSE	Thus, the results of our study show that the downregulation of <e1>miR-21</e1> contributes to the antitumor effects of IFN-beta and that miR-21 expression is negatively regulated by <e2>STAT3</e2> activation.
miRNA-corp.d178.s8.p2	NA	NA	FALSE	FALSE	FALSE	Thus, the results of our study show that the downregulation of miR-21 contributes to the antitumor effects of <e2>IFN-beta</e2> and that <e1>miR-21</e1> expression is negatively regulated by STAT3 activation.
miRNA-corp.d178.s8.p3	GENE_MIR	DOWN	FALSE	FALSE	FALSE	Thus, the results of our study show that the downregulation of miR-21 contributes to the antitumor effects of IFN-beta and that <e1>miR-21</e1> expression is negatively regulated by <e2>STAT3</e2> activation.
miRNA-corp.d180.s4.p0	NA	NA	FALSE	FALSE	FALSE	Association studies using all common variants detected in the 3' UTR of <e2>BACE1</e2> and the <e1>miR-29</e1> gene cluster did not identify an association with AD risk.
miRNA-corp.d180.s5.p0	NA	NA	FALSE	FALSE	FALSE	However, we did observe statistical interaction between rs535860 (<e2>BACE1</e2> 3' UTR) and rs34772568 (near <e1>miR29a</e1>.;  odds ratio [OR](interaction), 0.4;  95% confidence interval [CI], 0.17-0.96;  P=0.033). 
miRNA-corp.d181.s0.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	Differential regulation of <e2>interleukin-1 receptor-associated kinase-1</e2> (IRAK-1) and IRAK-2 by <e1>microRNA-146a</e1> and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.
miRNA-corp.d181.s0.p1	MIR_GENE	NEU	FALSE	FALSE	FALSE	Differential regulation of interleukin-1 receptor-associated kinase-1 (<e2>IRAK-1</e2>) and IRAK-2 by <e1>microRNA-146a</e1> and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.
miRNA-corp.d181.s0.p2	MIR_GENE	NEU	FALSE	FALSE	FALSE	Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and <e2>IRAK-2</e2> by <e1>microRNA-146a</e1> and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.
miRNA-corp.d181.s2.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In monocytes, increased expression of an NF-κB-regulated <e1>miRNA-146a</e1> down-regulates expression of the <e2>interleukin-1 receptor-associated kinase-1</e2> (IRAK-1), an essential component of Toll-like/IL-1 receptor signaling.
miRNA-corp.d181.s2.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In monocytes, increased expression of an NF-κB-regulated <e1>miRNA-146a</e1> down-regulates expression of the interleukin-1 receptor-associated kinase-1 (<e2>IRAK-1</e2>), an essential component of Toll-like/IL-1 receptor signaling.
miRNA-corp.d181.s2.p2	NA	NA	FALSE	FALSE	FALSE	In monocytes, increased expression of an NF-κB-regulated <e1>miRNA-146a</e1> down-regulates expression of the interleukin-1 receptor-associated kinase-1 (IRAK-1), an essential component of Toll-like/<e2>IL-1</e2> receptor signaling.
miRNA-corp.d181.s4.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In 66 control and AD samples we note a significant up-regulation of <e1>miRNA-146a</e1> coupled to down-regulation of IRAK-1 and a compensatory up-regulation of <e2>IRAK-2</e2>.
miRNA-corp.d181.s4.p2	MIR_GENE	DOWN	FALSE	FALSE	FALSE	In 66 control and AD samples we note a significant up-regulation of <e1>miRNA-146a</e1> coupled to down-regulation of <e2>IRAK-1</e2> and a compensatory up-regulation of IRAK-2.
miRNA-corp.d181.s5.p0	NA	NA	FALSE	FALSE	FALSE	Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in <e1>miRNA-146a</e1> and IRAK-2 expression in <e2>interleukin-1β</e2> (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p1	NA	NA	FALSE	FALSE	FALSE	Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in <e1>miRNA-146a</e1> and IRAK-2 expression in interleukin-1β (<e2>IL-1β</e2>) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p2	NA	NA	FALSE	FALSE	FALSE	Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in <e1>miRNA-146a</e1> and IRAK-2 expression in interleukin-1β (IL-1β) and <e2>amyloid-β-42</e2> (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p3	NA	NA	FALSE	FALSE	FALSE	Using miRNA-146a-, <e2>IRAK-1</e2>-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in <e1>miRNA-146a</e1> and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p4	NA	NA	FALSE	FALSE	FALSE	Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in <e1>miRNA-146a</e1> and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (<e2>Aβ42</e2>) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p5	NA	NA	FALSE	FALSE	FALSE	Using miRNA-146a-, IRAK-1-, or <e2>IRAK-2</e2> promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in <e1>miRNA-146a</e1> and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p6	NA	NA	FALSE	FALSE	FALSE	Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in <e1>miRNA-146a</e1> and <e2>IRAK-2</e2> expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p7	NA	NA	FALSE	FALSE	FALSE	Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in <e2>IRAK-1</e2> and increases in <e1>miRNA-146a</e1> and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p8	NA	NA	FALSE	FALSE	FALSE	Using <e1>miRNA-146a</e1>-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in <e2>interleukin-1β</e2> (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p9	NA	NA	FALSE	FALSE	FALSE	Using <e1>miRNA-146a</e1>-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (<e2>IL-1β</e2>) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p10	NA	NA	FALSE	FALSE	FALSE	Using <e1>miRNA-146a</e1>-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (IL-1β) and <e2>amyloid-β-42</e2> (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p11	NA	NA	FALSE	FALSE	FALSE	Using <e1>miRNA-146a</e1>-, <e2>IRAK-1</e2>-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p12	NA	NA	FALSE	FALSE	FALSE	Using <e1>miRNA-146a</e1>-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (<e2>Aβ42</e2>) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p13	NA	NA	FALSE	FALSE	FALSE	Using <e1>miRNA-146a</e1>-, IRAK-1-, or <e2>IRAK-2</e2> promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p14	NA	NA	FALSE	FALSE	FALSE	Using <e1>miRNA-146a</e1>-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and <e2>IRAK-2</e2> expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s5.p15	NA	NA	FALSE	FALSE	FALSE	Using <e1>miRNA-146a</e1>-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in <e2>IRAK-1</e2> and increases in miRNA-146a and IRAK-2 expression in interleukin-1β (IL-1β) and amyloid-β-42 (Aβ42) peptide-stressed HAG cells.
miRNA-corp.d181.s7.p0	NA	NA	FALSE	FALSE	FALSE	The NF-κB inhibitors curcumin, pyrrolidine dithiocarbamate or CAY10512 abrogated both <e2>IRAK-2</e2> and <e1>miRNA-146a</e1> expression, whereas IRAK-1 was up-regulated.
miRNA-corp.d181.s7.p1	NA	NA	FALSE	FALSE	FALSE	The NF-κB inhibitors curcumin, pyrrolidine dithiocarbamate or CAY10512 abrogated both IRAK-2 and <e1>miRNA-146a</e1> expression, whereas <e2>IRAK-1</e2> was up-regulated.
miRNA-corp.d181.s8.p0	NA	NA	FALSE	FALSE	FALSE	Incubation of a protected antisense miRNA-146a was found to inhibit <e1>miRNA-146a</e1> and restore <e2>IRAK-1</e2>, whereas IRAK-2 remained unaffected.
miRNA-corp.d181.s8.p1	NA	NA	FALSE	FALSE	FALSE	Incubation of a protected antisense miRNA-146a was found to inhibit <e1>miRNA-146a</e1> and restore IRAK-1, whereas <e2>IRAK-2</e2> remained unaffected.
miRNA-corp.d181.s9.p0	NA	NA	FALSE	FALSE	FALSE	These data suggest a significantly independent regulation of IRAK-1 and <e2>IRAK-2</e2> in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, <e1>miRNA-146a</e1>-mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.
miRNA-corp.d181.s9.p1	NA	NA	FALSE	FALSE	FALSE	These data suggest a significantly independent regulation of <e2>IRAK-1</e2> and IRAK-2 in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, <e1>miRNA-146a</e1>-mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.
miRNA-corp.d181.s9.p3	NA	NA	FALSE	FALSE	FALSE	These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, <e2>NF-κB</e2>-sensitive, <e1>miRNA-146a</e1>-mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.
miRNA-corp.d181.s9.p4	MIR_GENE	DOWN	FALSE	FALSE	FALSE	These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, <e1>miRNA-146a</e1>-mediated down-regulation of <e2>IRAK-1</e2> coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.
miRNA-corp.d181.s9.p5	MIR_GENE	UP	FALSE	FALSE	FALSE	These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, <e1>miRNA-146a</e1>-mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of <e2>IRAK-2</e2> expression drives an extensively sustained inflammatory response.
miRNA-corp.d181.s9.p6	NA	NA	FALSE	FALSE	FALSE	These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1β+<e2>Aβ42</e2> peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, <e1>miRNA-146a</e1>-mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.
miRNA-corp.d181.s9.p7	NA	NA	FALSE	FALSE	FALSE	These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in <e2>IL-1</e2>β+Aβ42 peptide-stressed HAG cells and that an inducible, NF-κB-sensitive, <e1>miRNA-146a</e1>-mediated down-regulation of IRAK-1 coupled to an NF-κB-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response.
miRNA-corp.d181.s10.p0	NA	NA	FALSE	FALSE	FALSE	The combinatorial use of NF-κB inhibitors with <e1>miRNA-146a</e1> or antisense miRNA-146a may have potential as a bi-pronged therapeutic strategy directed against <e2>IRAK-2</e2>-driven pathogenic signaling.
miRNA-corp.d181.s11.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	The interactive signaling of NF-κB and <e1>miRNA-146a</e1> further illustrate interplay between inducible transcription factors and pro-inflammatory miRNAs that regulate brain <e2>IRAK</e2> expression.
miRNA-corp.d182.s1.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	<e1>miR-34a</e1>, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits <e2>bcl2</e2> translation.
miRNA-corp.d182.s2.p5	MIR_GENE	TARGET	FALSE	FALSE	FALSE	During a research for miRNAs that are differentially expressed in cerebral cortex of APPswe/PSDeltaE9 mice (a model for Alzheimer's disease) and age-matched controls, one candidate miRNA that is relatively highly expressed, <e1>miR-34a</e1>, was studied further because sequence analysis suggested a likely interaction with the 3'-untranslated region of <e2>bcl2</e2> mRNA.
miRNA-corp.d182.s5.p0	MIR_GENE	INVCORR	FALSE	FALSE	FALSE	We show that the expression of <e1>miR-34a</e1> is inversely correlated with the protein level of <e2>bcl2</e2> in APPswe/PSDeltaE9 mice and age-matched controls, and miR-34a expression directly inhibits bcl2 translation in SH-SY5Y cells.
miRNA-corp.d182.s5.p1	NA	NA	FALSE	FALSE	FALSE	We show that the expression of <e1>miR-34a</e1> is inversely correlated with the protein level of bcl2 in APPswe/PSDeltaE9 mice and age-matched controls, and miR-34a expression directly inhibits <e2>bcl2</e2> translation in SH-SY5Y cells.
miRNA-corp.d182.s5.p2	NA	NA	FALSE	FALSE	FALSE	We show that the expression of miR-34a is inversely correlated with the protein level of <e2>bcl2</e2> in APPswe/PSDeltaE9 mice and age-matched controls, and <e1>miR-34a</e1> expression directly inhibits bcl2 translation in SH-SY5Y cells.
miRNA-corp.d182.s5.p3	MIR_GENE	DOWN	FALSE	FALSE	FALSE	We show that the expression of miR-34a is inversely correlated with the protein level of bcl2 in APPswe/PSDeltaE9 mice and age-matched controls, and <e1>miR-34a</e1> expression directly inhibits <e2>bcl2</e2> translation in SH-SY5Y cells.
miRNA-corp.d182.s6.p0	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Consistently, <e1>miR-34a</e1> knockdown through antisense LNA oligonucleotides increased the level of <e2>bcl2</e2> protein in SH-SY5Y cells, which was accompanied by a decrease of active caspase-3.
miRNA-corp.d182.s6.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Consistently, <e1>miR-34a</e1> knockdown through antisense LNA oligonucleotides increased the level of bcl2 protein in SH-SY5Y cells, which was accompanied by a decrease of active <e2>caspase-3</e2>.
miRNA-corp.d182.s7.p0	NA	NA	FALSE	FALSE	FALSE	Western blot analysis of active <e2>caspase-3</e2> showed higher levels in APPswe/PSDeltaE9 mice and stable transfecant cell line of <e1>miR-34a</e1> than in controls.
miRNA-corp.d182.s8.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	These findings suggested that <e2>bcl2</e2> is an important functional target for <e1>miR-34a</e1>, and the abnormal expression of miR-34a may contribute to the pathogenesis of Alzheimer's disease, at least in part by affecting the expression of bcl2.
miRNA-corp.d182.s8.p2	NA	NA	FALSE	FALSE	FALSE	These findings suggested that bcl2 is an important functional target for <e1>miR-34a</e1>, and the abnormal expression of miR-34a may contribute to the pathogenesis of Alzheimer's disease, at least in part by affecting the expression of <e2>bcl2</e2>.
miRNA-corp.d182.s8.p3	NA	NA	FALSE	FALSE	FALSE	These findings suggested that <e2>bcl2</e2> is an important functional target for miR-34a, and the abnormal expression of <e1>miR-34a</e1> may contribute to the pathogenesis of Alzheimer's disease, at least in part by affecting the expression of bcl2.
miRNA-corp.d182.s8.p5	MIR_GENE	NEU	FALSE	FALSE	FALSE	These findings suggested that bcl2 is an important functional target for miR-34a, and the abnormal expression of <e1>miR-34a</e1> may contribute to the pathogenesis of Alzheimer's disease, at least in part by affecting the expression of <e2>bcl2</e2>.
miRNA-corp.d186.s5.p0	MIR_GENE	NEU	FALSE	FALSE	FALSE	<e1>miR-133b</e1> regulates the maturation and function of midbrain DNs within a negative feedback circuit that includes the paired-like homeodomain transcription factor <e2>Pitx3</e2>.
miRNA-corp.d187.s4.p0	MIR_GENE	DOWN	FALSE	TRUE	FALSE	Drosophila <e2>e2f1</e2> and dp messenger RNAs are translationally repressed by <e1>let-7</e1> and miR-184*, respectively.
miRNA-corp.d187.s4.p1	MIR_GENE	DOWN	FALSE	TRUE	FALSE	Drosophila <e2>e2f1</e2> and dp messenger RNAs are translationally repressed by let-7 and <e1>miR-184</e1>*, respectively.
miRNA-corp.d187.s6.p0	NA	NA	FALSE	FALSE	FALSE	Genetic deletion of <e1>let-7</e1>, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic <e2>LRRK2</e2>.
miRNA-corp.d187.s6.p1	NA	NA	FALSE	FALSE	FALSE	Genetic deletion of let-7, antagomir-mediated blockage of <e1>let-7</e1> and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic <e2>LRRK2</e2>.
miRNA-corp.d187.s6.p2	NA	NA	FALSE	FALSE	FALSE	Genetic deletion of let-7, antagomir-mediated blockage of let-7 and <e1>miR-184</e1>* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic <e2>LRRK2</e2>.
miRNA-corp.d187.s6.p3	NA	NA	FALSE	FALSE	FALSE	Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to <e1>let-7</e1> each had toxic effects similar to those of pathogenic <e2>LRRK2</e2>.
miRNA-corp.d187.s7.p0	MIR_GENE	UP	FALSE	FALSE	FALSE	Conversely, increasing the level of let-7 or <e1>miR-184</e1>* attenuated pathogenic <e2>LRRK2</e2> effects.
miRNA-corp.d187.s7.p1	MIR_GENE	UP	FALSE	FALSE	FALSE	Conversely, increasing the level of <e1>let-7</e1> or miR-184* attenuated pathogenic <e2>LRRK2</e2> effects.
miRNA-corp.d193.s1.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	RESULT; <e2>EiF4E3</e2> was the most likely potential targeting protein of <e1>microRNA-338</e1>.
miRNA-corp.d193.s6.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	[Interaction of <e1>microRNA-338</e1> and its potential targeting protein <e2>eiF4E3</e2>].
miRNA-corp.d193.s8.p0	MIR_GENE	TARGET	TRUE	FALSE	FALSE	The secondary structure of local region of <e2>eiF4E3</e2> recognizing <e1>microRNA-338</e1> was conservative.
miRNA-corp.d193.s10.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	CONCLUSION; <e1>MicroRNA-338</e1> can recognize the 3'UTR of <e2>eiF4E3</e2> while it has no significant effect on the expression of eiF4E3.
miRNA-corp.d193.s10.p1	NA	NA	FALSE	FALSE	FALSE	CONCLUSION; <e1>MicroRNA-338</e1> can recognize the 3'UTR of eiF4E3 while it has no significant effect on the expression of <e2>eiF4E3</e2>.
miRNA-corp.d195.s0.p1	MIR_GENE	NEU	FALSE	FALSE	FALSE	The <e2>PTEN</e2>-regulating microRNA <e1>miR-26a</e1> is amplified in high-grade glioma and facilitates gliomagenesis in vivo.
miRNA-corp.d195.s4.p0	MIR_GENE	TARGET	FALSE	FALSE	FALSE	Here we report the identification <e1>miR-26a</e1> as a direct regulator of <e2>PTEN</e2> expression.
miRNA-corp.d195.s5.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	We also show that <e1>miR-26a</e1> is frequently amplified at the DNA level in human glioma, most often in association with monoallelic <e2>PTEN</e2> loss.
miRNA-corp.d195.s6.p1	MIR_GENE	DOWN	FALSE	FALSE	FALSE	Finally, we demonstrate that <e1>miR-26a</e1>-mediated <e2>PTEN</e2> repression in a murine glioma model both enhances de novo tumor formation and precludes loss of heterozygosity and the PTEN locus.
miRNA-corp.d195.s6.p2	NA	NA	FALSE	FALSE	FALSE	Finally, we demonstrate that <e1>miR-26a</e1>-mediated PTEN repression in a murine glioma model both enhances de novo tumor formation and precludes loss of heterozygosity and the <e2>PTEN</e2> locus.